Clinical Trial

Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

Study acronym: CANOPE
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy,...) in patients with pancreatic adenocarcinoma. The effectiveness and tolerance of these treatments in current practice is also evaluated.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-03-08; most recent amendment 2025-03-21.
Status change: Not Yet Recruiting → Recruiting 2023-09-27
Trial Details
NCT Number NCT05776342
Lead Sponsor GERCOR - Multidisciplinary Oncology Cooperative Group
Conditions Pancreatic Adenocarcinoma
Enrollment 4,050 participants
Start Date 2003-01-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2031-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-25